Nancy Thornberry - Jan 8, 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Jan 8, 2022
Transactions value $
$0
Form type
4
Date filed
1/11/2022, 06:54 PM
Previous filing
Jun 21, 2021
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Award $0 +627 +33.28% $0.00 2.51K Jan 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person has reported prior awards of restricted stock units in Table II of Form 4. This total reported in Column 5 includes 1884 previously reported restricted stock units and 627 shares acquired pursuant to vesting of restricted stock units.